ROCKVILLE, Md., Jan. 28, 2025 /PRNewswire/ — Xiao-I Corporation (NASDAQ: AIXI), a leading artificial intelligence company (“Xiao-I”), today announced the successful deployment of its 8-million-HKD AI-powered HR system for a Hong Kong public sector client. This milestone underscores Xiao-I’s growing influence in public sector digitization and highlights the scalability of its Model-as-a-Service (MaaS) platform, which has already driven successful AI adoption across Asia and is poised to support the company’s upcoming U.S. expansion.

The Hua Zang Large Language Model (LLM), the core engine behind the solution, enabled the client to streamline HR operations—including talent management, policy compliance, and employee engagement—with unprecedented efficiency. By leveraging Xiao-I’s proprietary AI architecture, the system achieved high accuracy and transparency while operating on minimal computing resources, reducing both deployment complexity and long-term operational costs.

Key Advantages of the Hua Zang LLM in Public Sector Deployment

• Rapid Implementation: Pre-trained module libraries cut deployment time by 40%, enabling the client to operationalize the system within weeks.
• Cost-Effective Scalability: Optimized for low-resource environments, the solution eliminates the need for expensive GPU clusters, aligning with public sector budget constraints.
• Interpretable AI: Transparent decision-making processes ensure compliance with regulatory standards, fostering trust in automated HR outcomes.
• Cross-Industry Adaptability: Modular design allows seamless customization for education, healthcare, and other government verticals.

“This project exemplifies how Xiao-I’s AI solutions empower public institutions to modernize efficiently,” said Xiao-I’s CEO Mr. Hui Yuan. “The Hong Kong deployment not only validates our MaaS platform’s versatility but also reinforces our commitment to delivering scalable, ethical AI—principles that will guide our entry into the U.S. market later this year.”

The Hong Kong initiative builds on Xiao-I’s proven track record in Asia, where its AI solutions have been adopted by governments and enterprises for tasks ranging from citizen services to supply chain optimization. The company’s focus on cost-effective, high-impact AI aligns with global demand for technologies that balance performance with fiscal responsibility—a cornerstone of its upcoming U.S. market strategy.

Looking Ahead

Xiao-I plans to replicate this success in North America, tailoring its Hua Zang LLM to address pressing needs in public administration and corporate sectors. The Hong Kong case study will serve as a blueprint for demonstrating how AI can drive operational excellence without prohibitive upfront investments.

About Xiao-I Corporation

Xiao-I Corporation is a leading cognitive intelligence enterprise in China that offers a diverse range of business solutions and services in artificial intelligence, covering natural language processing, voice and image recognition, machine learning, and affective computing. Since its inception in 2001, the Company has developed an extensive portfolio of cognitive intelligence technologies that are highly suitable and have been applied to a wide variety of business cases. Xiao-I powers its cognitive intelligence products and services with its cutting-edge, proprietary AI technologies to enable and promote industrial digitization, intelligent upgrading, and transformation. For more information, please visit: www.xiaoi.com.

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company’s ability to achieve its goals and strategies, the Company’s future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, fluctuations in general economic and business conditions in China, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, including under the section entitled “Risk Factors” in its annual report on Form 20-F filed with the SEC on April 30, 2024, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For investor and media inquiries, please contact:
Ms. Berry Xia
Email: ir@xiaoi.com

The cutting-edge OncoPortal™ Mutation Tracker add-on module enables precision monitoring of evolving genomic cancer drivers

BOSTON, MA and ROLLE, Switzerland, Jan. 28, 2025 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has unveiled the OncoPortal™ Mutation Tracker — a longitudinal MRD tracking tool designed for disease monitoring in the context of oncology. This innovation underscores SOPHiA GENETICS’ commitment to advancing data-driven approaches for improved oncology insights.

Tracking genomic variants across multiple time points in the same patient is becoming increasingly critical in cancer care, particularly for identifying treatment resistance or detecting residual cancer cells, such as in Measurable Residual Disease (MRD) management. The integration of longitudinal tracking capabilities with next-generation sequencing (NGS) allow the parallel detection of cancer-specific genetic mutations at very low frequencies. This combined approach enables early identification of residual disease or emerging variants, providing a more precise assessment of disease burden, better stratification of high-risk patients, and the ability to tailor treatments to the cancer’s unique genomic profile.

The OncoPortal™ Mutation Tracker augments the SOPHiA DDM™ Platform’s core analytical capabilities to allow clinical researchers to longitudinally monitor evolving genomic variants across multiple time points, providing a comprehensive view of disease evolution. The OncoPortal™ Mutation Tracker enhances workflow efficiency for longitudinal variant tracking by offering flexible low frequency variant selection, customizable threshold settings, and reporting features to generate longitudinal graphical representations, simplifying the process of tracking and analyzing genetic changes over time.

“The ability to reliably track low frequency variants longitudinally is a game-changer because it allows the detection of even the smallest traces of cancer that can evade traditional methods of testing and ultimately drive relapse,” said Philippe Menu, M.D., Ph.D., Chief Medical Officer and Chief Product Officer, SOPHiA GENETICS. “With this new longitudinal tracking capability, we offer a highly customizable, user-friendly solution to enable the generation of novel insights for clinical research. Precise tracking of key genomic variants over time has the potential to eventually enable earlier intervention and more tailored disease management, which may lead to better long-term outcomes for patients.”

“This longitudinal interface represents the solution we’ve been seeking to unite our oncologists in embracing broader adoption of NGS. It’s the missing piece that unlocks a new frontier in personalized, data-driven medicine,” said Dr. Christophe Marzac, Head of the Hematology-Immunology Unit, Gustave Roussy Institute.

For more information on the OncoPortal™ Mutation Tracker, visit SOPHiAGENETICS.com.

About SOPHiA GENETICS 

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to transform patient care by expanding access to data-driven medicine globally. It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.com and connect with us on LinkedIn.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact support@sophiagenetics.com to obtain the appropriate product information for your country of residence. 

SOPHiA GENETICS Forward-Looking Statements:

This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products, and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of the date hereof. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. 

NEW YORK, Jan. 28, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on January 28th

• Federal Reserve begins two-day policy meeting today
• Traders and investors anticipate rates to go unchanged
• General Motors sees shares rise amid strong profit and sales estimates

Watch NYSE TV Live every weekday 9:00-10:00am ET 

HOUSTON, Jan. 28, 2025 /PRNewswire/ — As pioneers in biomedical imaging and neuroscience, the researchers at the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system, have long appreciated the physiologic connections shared between the brain and the body. Now it is possible to image connected physiologic systems over the entire body at the same time. A new class of positron emission tomography (PET) scanners is making it possible to image multiple organs and organ systems – from the brain to the heart to the gut – simultaneously with high precision, revealing scientific and clinical insights. Mass General Brigham (MGB) is building a clinical translation and research program around this new technology.

Acquisition of this novel PET technology has been made possible through two grants awarded to Ciprian Catana, MD, PhD, Professor of Radiology at Harvard Medical School and Director of the Molecular Imaging Core at the Athinoula A. Martinos Center, by the National Institutes of Health and Massachusetts Life Sciences Center. Dr. Catana has long been an innovator in PET technologies that support scientific understanding of the brain and the body. Demand for PET imaging at MGH has been steadily increasing. “These latest awards will increase our molecular imaging capabilities to help meet the growing demand for PET among the more than 200 researchers performing studies at MGH, Brigham and Women’s Hospital, and Massachusetts Institute of Technology” says Bruce Rosen, MD, PhD, Director at the Martinos Center.

“We selected the United Imaging uMI Panorama GS because of the company’s commitment to develop this novel class of PET/CT scanners,” says Dr. Catana. The uMI Panorama GS is the first PET device to bring together the powerful combination of high spatial resolution, sub-200 picosecond TOF timing resolution, and a large 148 cm of PET coverage to yield sensitivity that is 40 times higher than a conventional PET scanner. “These unique capabilities will give researchers and clinicians across MGB the ability to simultaneously image physiologic systems over the whole body for the first time with extremely high sensitivity and resolution that will lead to a new understanding of the body and disease,” says Dr. Catana. This project is the first phase of a clinical translation research program at MGB that is being led by Dr. Catana in his other role as Director of Collaborative Research and Innovation in Molecular Imaging and Dr. Marcelo Di Carli, MD, Chief of the Division of Nuclear Medicine at Brigham and Women’s Hospital.

Molecular imaging, which uses radiopharmaceutical agents injected into the body to image physiologic function and disease, continues to grow as a field for scientific discovery and diagnosis. “At United Imaging, we are committed to investing in these next-generation technologies that can support the academic mission for scientific discovery and provide equal healthcare for all,” says Jeffrey Bundy, PhD, CEO of United Imaging in North America. United Imaging created the first total-body PET/CT, the uEXPLORER, in 2019, through the NIH-funded Explorer consortium between U.C. Davis, Yale University, and the University of Pennsylvania. The new uMI Panorama GS is the second such long-axial FOV PET/CT system from United Imaging. Abram Voorhees, PhD, Senior Director of Academic Alliances emphasizes the importance of this collaboration: “We are excited to support the vision at the Martinos Center and believe that this work will yield both a greater understanding of the body and new clinical applications for advanced whole-body PET/CT at MGB.” The uMI Panorama GS is planned to be operational in the summer of 2025.

ABOUT A. A. MARTINOS CENTER

The Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital is one of the world’s premier research centers devoted to the development and application of advanced biomedical imaging technologies. Our mission is to revolutionize imaging for the advancement of science and medicine by inspiring, educating, and informing.  The Center is part of the Department of Radiology at Massachusetts General Hospital and affiliated with both Harvard Medical School and MIT. Our faculty are developing first-of-a-kind tools and applying them to solve challenges in neuroscience, oncology, cardiology and other clinical domains. Mass General conducts the largest hospital-based research program in the United States and is the oldest and largest teaching affiliate of Harvard Medical School. It is a founding member of the Mass General Brigham integrated health care system.

ABOUT MASS GENERAL BRIGHAM

Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.

ABOUT UNITED IMAGING

At United Imaging, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment. Founded in 2011, our company has subsidiaries and R&D centers across the world. Our North American headquarters in Houston includes our corporate offices, factory, product showroom, service training center, and service parts distribution center. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All™, we help drive industry progress and bold change.

BEIJING, Jan. 28, 2025 /PRNewswire/ — TuanChe Limited (NASDAQ: TC) (“TuanChe” or the “Company”), a leading automotive marketplace platform, today announced its plan to adopt DeepSeek’s newly released R1 model as the technological foundation for its intelligent service system. This initiative aims to further enhance TuanChe’s technological capabilities in smart marketing and user interaction, delivering more precise, efficient, and intelligent automotive consumption experiences for its users.

The DeepSeek R1 model has enhanced its advanced reasoning capabilities through a multi-stage loop training approach, demonstrating exceptional performance in mathematical operations, code analysis, and natural language reasoning tasks. Notably, its breakthroughs in reinforcement learning allow DeepSeek R1 to autonomously learn complex reasoning strategies through self-play and evolution without reliance on extensive labeled data.

TuanChe has consistently focused on improving platform service efficiency and user experience through independent research and technology optimization. The selection of the DeepSeek R1 model underscores its robust reasoning abilities and self-learning characteristics. By deeply integrating the R1 model, TuanChe will optimize its user data analysis processes and intelligent recommendation systems, enhancing the accuracy and efficiency of its services.

TuanChe plans to incorporate the DeepSeek R1 model into its intelligent marketing and interaction platform, leveraging R1’s deep learning algorithms to comprehensively analyze user behavior and market data. This will enable more personalized service recommendations. Additionally, the open-source nature of the R1 model provides TuanChe with the flexibility for secondary development and scenario-specific applications, allowing the company to meet diverse customer needs and business requirements.

TuanChe stated that adopting DeepSeek R1 is a significant milestone in its digital and intelligent strategic upgrade. Looking ahead, TuanChe will continue to introduce innovative technologies and services to further enhance its users’ automotive consumption experience.”
With the gradual integration of DeepSeek R1 into its operations, TuanChe is expected to deliver smarter, more personalized services to its users in the near future, driving the digital transformation of the automotive marketplace. This strategic decision not only injects new momentum into TuanChe’s growth but also paves the way for the application of intelligent technologies in the automotive industry.

About TuanChe Limited

Founded in 2010, TuanChe Limited (NASDAQ: TC) is China’s leading automotive marketplace platform. TuanChe is dedicated to connecting automotive consumers with manufacturers, dealers, and service providers. By integrating its digital platforms with offline sales events, TuanChe offers comprehensive automotive marketing and transaction services. Through its integrated marketing strategies, TuanChe transforms individual and independent car purchases into large-scale group buying experiences, using an interactive many-to-many model.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company’s business plans and development, business outlook, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Media Enquiries:

Lydia Hu
lydia.hu@tuanche.com

Setting a New Standard for Innovation and Environmental Responsibility in the Pool Care Industry

RICHMOND, Texas, Jan. 28, 2025 /PRNewswire/ — Beatbot, a global leader in high-end robotic pool cleaning, has been recognized with the 2025 SEAL Business Sustainability Award for its groundbreaking robotic pool skimmer, the Beatbot iSkim Ultra. Honored with the prestigious Sustainable Product Award, this innovation is the first robotic pool cleaner to achieve this remarkable recognition, highlighting Beatbot’s commitment to innovation and sustainability while setting a new benchmark in the industry.

The SEAL (Sustainability, Environmental Achievement, and Leadership) Awards are among the most prestigious accolades in the field of sustainability, celebrating organizations and leaders who drive meaningful progress on the world’s most urgent environmental challenges. The awards highly recognized Beatbot for seamlessly combining exceptional cleaning efficiency with eco-conscious innovation, offering users a sustainable choice that enhances quality of life and promotes a healthier environment.

Technological Innovation Empowering Sustainability

By significantly reducing energy, materials, chemicals, and water consumption, the Beatbot iSkim Ultra minimizes environmental impact while maximizing cleanliness. This achievement is mainly powered by innovative and advanced sustainable features including:

• ClearWater™ Clarification System: This system utilizes a natural clarifier made from recycled crab shells to remove dirt, oils, and metal residues, ensuring pool water remains clear and safe without harming the environment. This sustainable solution promotes long-term pool health while preventing harmful chemicals from entering ecosystems.
• Solar-Powered Innovation: Featuring a 24W solar panel with its SolarTrack™ light energy tracking, the iSkim Ultra efficiently harnesses sunlight, minimizing energy consumption and lowering the carbon footprint associated with pool maintenance, thereby contributing to global greenhouse gas reduction efforts. In cases of insufficient sunlight, when the battery level drops, the iSkim Ultra initiates light-chasing to locate adequate sunlight for charging, resuming cleaning once it has enough battery power.
• Sustainable Packaging: The iSkim Ultra is packaged using TPCH certified recyclable materials, reducing waste and promoting eco-conscious practices throughout the product’s lifecycle.

In addition, the Beatbot iSkim Ultra is equipped with an industry-leading array of 20 sensors and a high-performance six-axis IMU, enabling precise scanning and efficient path planning. It also features the industry’s first Dual-roller brushes and a 9L extra-large basket, ensuring efficient and comprehensive pool cleaning while significantly reducing the frequency of water changes and improving energy efficiency. These innovations all together position Beatbot to lead the way in sustainability.

A Shared Honor in the Pursuit of a Sustainable Future

“We are deeply honored to receive the SEAL Awards 2025, a testament to our unwavering commitment to sustainability and continuous investments in green innovation,” said York Guo, CMO of Beatbot. “At Beatbot, we believe innovation and responsibility go hand in hand. Beyond the iSkim Ultra, innovations like the Amphibious RoboTurtle, unveiled at CES, represent just one of many pathways toward a sustainable future. By choosing Beatbot, users are not simply opting for an innovative pool cleaning solution; they are joining us in creating a more sustainable future. This recognition is not just an honor for Beatbot—it’s a shared achievement with our users, who are true partners in this journey toward a better tomorrow, for the industry and the world at large.”

Looking ahead, Beatbot will continue to work at the forefront alongside a broader community of like-minded users and partners, striving for more innovations and possibilities for a sustainable future. To explore Beatbot’s latest innovations, including the AquaSense 2 series and other eco-friendly solutions, visit www.beatbot.com.

About Beatbot

Beatbot is a technology brand redefining smart pool care and is dedicated to the global robotization of swimming pool environments. Founded by industry experts with over 10 years of experience in leading home robotics companies, the company is growing rapidly, with offices in multiple countries and a strong R&D team, taking up 70% of the workforce. Pioneering core technologies like brushless water pumps, AUV spatial locomotion, sonar laser SLAM, and space mapping navigation algorithms, Beatbot has secured numerous patents and pioneered industry-first innovations. The company currently holds over 216 patents (granted and under application), including 124 patents for inventions.

The rise in compute density and larger clusters, along with more powerful cooling systems, stretches current infrastructure limits and complicates new deployments

NEW YORK, Jan. 28, 2025 /PRNewswire/ — The enormous demand for generative Artificial Intelligence (AI) has led to unprecedented CAPEX by hyperscalers, foundation model builders, and those capitalizing on the exploding demand for compute. Global technology intelligence firm ABI Research‘s discussions across the value chain have exposed the dynamics in the rapidly evolving AI server market, powering the race to increase the efficiency and accuracy of generative AI models.

“The rapid pace of silicon innovation has left space for differentiation,” explains Paul Schell, Industry Analyst at ABI Research. “The expertise needed to plan, deploy, and run today’s high-performance accelerator clusters has created the opportunity for those with the in-house engineering talent to leverage their organizational capital, capture more value, and ride the generative AI wave.”

The professional services offered by Tier One OEMs Supermicro, HPE, Dell, and Lenovo, and challengers like Penguin Solutions, are increasingly seen as a necessary part of their AI server go-to-market. Furthermore, the offering of ‘burnt-in’ solutions that cater to various end-customers and deployment sizes helps end customers deploy with fewer hurdles, accelerating the monetization of their AI product.

“Time to market matters more than usual in the current stage of the AI race, and AI server vendors able to offer their customers the agility they seek will come out on top”, explains Paul Schell. “In addition, cluster management software that can squeeze more out of the pricey hardware is of enormous value – both monetary and operational – for customers without an extensive legacy in AI or HPC compute.”

These findings are from ABI Research’s AI Server OEM/ODM Market report. This report is part of the company’s AI & Machine Learning research service, which includes research, data, and ABI Insights. 

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research是一家全球性的技术情报公司，拥有得天独厚的优势，充当终端市场公司和技术解决方案提供商之间的桥梁，通过提供独家研究和专业性指导，推动成功的技术实施和提供经证明可吸引和留住客户的战略，无缝连接这两大主体。

For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.

Contact Info: 

Global
Deborah Petrara                                                           
Tel: +1.516.624.2558                                                   
pr@abiresearch.com     

STUTTGART, Germany, Jan. 28, 2025 /PRNewswire/ — Hesai Technology (Nasdaq: HSAI), Outsight, and Embotech AG announce a strategic collaboration to deliver cutting-edge lidar technology and perception software for Embotech’s AVM technology deployed in BMW facilities and known internally at BMW as Automated Driving In-Plant (AFW). This collaboration brings together industry leaders in autonomous driving solutions and sensing technology.

Embotech is the system provider for BMW’s recently announced Automated Driving In-Plant series operation and global rollout. For the AVM solution, Outsight plays a key role with its advanced lidar software platform that tracks the ego-vehicle and the surrounding obstacles within BMW’s production facilities, while Hesai supplies its industry-leading lidar sensors, renowned for their accuracy and reliability, which act as the “eyes” of the AVM system.

This AVM technology, initially implemented for the BMW 5 Series and 7 Series in Dingolfing, is now also in use for the MINI Countryman and other BMW models in Leipzig. At the Dingolfing plant, new vehicles are driven fully autonomously—without a driver—over a route exceeding one kilometer, from the assembly halls, through the “short test course,” to the finishing area. Once the cars leave the production line, the factory establishes a secure connection to the vehicles, controlling their movement through the quality assurance test drive. This approach eliminates the need to transport human workers back to the production line after each car has reached its final parking destination.

Embotech, Outsight and Hesai have successfully collaborated for several years, jointly advancing lidar and perception solutions for autonomous driving. The companies are global leaders in their respective fields, driving innovation in lidar as well as perception technology. This latest strategic collaboration builds upon a strong foundation, enabling the companies to provide best-in-class technology for AVM, which is safety rated, fulfilling the highest performance and availability requirements.

“Hesai is proud to partner with Embotech and Outsight to deliver cutting-edge lidar technology for BMW’s Automated Vehicle Marshalling (AVM) system,” says Dr. David Li, CEO and Co-founder of Hesai Technology. “This state-of-the-art technology demonstrates the high level of precision and safety offered by our lidar and Outsight’s perception software for Embotech’s autonomous driving solutions. We look forward to continuing our collaboration and bringing this technology to more factories around the world.”

“The combination of Outsight’s sophisticated lidar software platform and Hesai’s reliable lidar sensors perfectly complements Embotech’s autonomous driving expertise,” says Dr. Alexander Domahidi, CTO and Founder of Embotech. “This collaboration ensures the highest standards of safety and efficiency in BMW’s automated vehicle operations.”

According to Raul Bravo, President and co-founder at Outsight, “Our collaboration with Embotech, Hesai, and BMW highlights the increasing maturity of LiDAR technology, particularly the software underpinning it. Its application to real-world factory conditions demonstrates its ability to enhance industrial safety and efficiency, while underlining the importance of a comprehensive framework to realise the potential of autonomous driving.”

The integrated solution is now actively supporting the marshalling of newly manufactured vehicles through various stages of the production and logistics process in three BMW facilities. This deployment marks the initial phase in a global rollout to multiple plants across Europe and North America.

This collaboration represents a significant step forward in industrial automation. It combines Embotech’s proven autonomous driving capabilities with best-in-class perception technology from Outsight and Hesai.

About Hesai

Hesai Technology (Nasdaq: HSAI) is the global leader in lidar technology for automotive and robotics applications. The company supplies ADAS lidar to 6 of the top 10 global OEMs by revenue and is ranked No. 1 in the ADAS lidar market globally, with a 26% market share. Hesai has established a strong presence in Europe, the US and Asia, with customers located in over 40 countries. The company will continue to invest in its resources and technical advancements, leveraging cutting-edge technology to shape the future of mobility.

As Hesai celebrates a decade of innovation, the company continues to expand its global reach, serving customers in over 40 countries across Asia, the US and Europe. Through its continued advancements in lidar technology, including the deployment of over 1,700 patents globally, Hesai is pushing the boundaries of mobility and shaping the future of industries around the world.

For more information: www.hesaitech.com

About Embotech

Embotech is an award-winning provider of cutting-edge autonomous driving solutions for logistics, with a focus on Automated Vehicle Marshalling (AVM) in passenger car factories and Automated Terminal Trucks (ATT) at port terminals and logistic centers. The company delivers safe and reliable autonomous transportation by leveraging the real-time optimization technology that it has been developing since 2013.

For more information: www.embotech.com

About Outsight

Outsight’s software solutions track and digitizes the motion of People and Vehicles using 3D LiDAR data.

Operators of transportation hubs like airports, train stations but also sport venues, road infrastructures and industrial sites get access to accurate and anonymous Spatial Intelligence data, in order to improve operations and increase security.

We believe that accelerating 3D perception technology adoption through robust and scalable Spatial AI solutions will significantly contribute to a smarter, safer, and more sustainable world.

For more information: www.outsight.ai